Results 221 to 230 of about 10,893,049 (312)

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Pharmacogenetics of steady-state metabolism, pharmacokinetics, and adverse effects of voriconazole in healthy participants. [PDF]

Drug Metab Dispos
Wu YP, Gelal A, Moon C, Metzger IF, Lu JBL, Callaghan JT, Skaar TC, Desta Z.   +7 more
europepmc   +1 more source

Accelerated Progression of Gait Impairment in Parkinson's Disease and REM Sleep Without Atonia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective People with Parkinson's disease (PD) and rapid eye movement (REM) sleep without atonia (RSWA) often have more severe gait disturbances compared to PD without RSWA. The association between the presence and expression of RSWA and the rate of progression of gait impairment in PD is unknown.
Sommer L. Amundsen‐Huffmaster, Jae Woo Chung, Maria E. Linn‐Evans, Matthew N. Petrucci, Chiahao Lu, Destiny J. Weaver, Joshua De Kam, Scott E. Cooper, Paul J. Tuite, Aleksandar Videnovic, Michael J. Howell, Colum D. MacKinnon   +11 more
wiley   +1 more source

Inflammatory signatures during the steady state of sickle cell disease in African children

Allotey EA, Adedia D, Amponsah JA, Boakye AA, Frimpong A, Gyamfi J, Ninsin E, Offei H, Kwansa-Bentum H, Kpeli GS, Tetteh JKA, Amegan-Aho KH, Atadja PW, Mosi L, Duedu KO.   +14 more
europepmc   +1 more source

Study on the relationship between the steady-state rolling resistance of radial tires and energy consumption of electric vehicles. [PDF]

Sci Rep
Wang Q, Li A, Yan J.
europepmc   +1 more source

Differential Contribution of Monocytes to Heart Macrophages in Steady-State and After Myocardial Infarction

Circulation Research, 2014
T. Heidt, G. Courties, Partha Dutta, H. Sager, Matthew Sebas, Y. Iwamoto, Yuan Sun, Nicolas Da Silva, Peter R. Panizzi, A. M. van der Laan, F. Swirski, R. Weissleder, M. Nahrendorf   +12 more
semanticscholar   +1 more source

Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan, John R. Mills, Paulina Vargas, Naveen K. Paramasivan, Connie E. Lesnick, Eati Basal, Surendra Dasari, James P. Fryer, Shannon R. Hinson, Joseph Laporta, Amy Espinal, Dennis Fitzgerald, Carolina Garcia, Anna E. Morenkova, Paola Pergami, Anna Shah, Andrew Knight, Reghann LaFrance Corey, Vanda A. Lennon, Anastasia Zekeridou, Sean J. Pittock, Divyanshu Dubey, Andrew McKeon   +22 more
wiley   +1 more source

The relationship between auditory steady-state response and behavioural audiometry in hearing estimation for infants: a meta-analysis. [PDF]

Syst Rev
Huang X, Kluk K, Perugia E.
europepmc   +1 more source

Morphodynamics: Rivers beyond steady state

, 2015
Michael Church, Robert Ferguson
semanticscholar   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source